Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-23-015964

10% owner acquired 188,757 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Morris Jeffrey Allen 10% owner 2023-05-08 Conversion +188,757 $2.86 $540,223 3,995,747 D
Loading xslF345X04/ownership.xml…